SkyAI, Inc.
NASDAQ:STSSMedical - Instruments & Supplies
+$0.00 today
- Market cap
- $55.65M
- Beta
- 2.02
- P/E (TTM)
- 1.3
- EPS (TTM)
- $0.91
Volume 0.00M
Average 0.37M
STSS Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
SkyAI, Inc.NASDAQ: STSS
Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026
Cash & equivalents rises 3.6% from a year ago
Cash & equivalents stood at $12.32M at the end of Q1 FY2026, up 3.6% from a year earlier and up 18.7% from the prior quarter. Over 3 fiscal years it compounded at +35.5% a year.
Context
- Cash & equivalents amounted to 6.8% of total assets at the end of Q1 FY2026, down 56.1 pp from a year earlier.
- Cash & equivalents increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +3.6% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 10.38M USD
- Year-over-year change
- +1101.6%
- 4-year CAGR
- +62.8%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 10.38M | +1101.6% |
| FY2024 | 2024-12-31 | 864.04K | -71.3% |
| FY2023 | 2023-12-31 | 3.01M | -27.8% |
| FY2022 | 2022-12-31 | 4.17M | +182.0% |
| FY2021 | 2021-12-31 | 1.48M | — |
Cash & Equivalents vs competitors
How STSS compares with its peers on the latest reported figures
- STSS's Mar 2026 cash & equivalents of $12.32M is the 5th highest of the 10 companies compared; the peer median is $10.51M.
- Its year-over-year change of +3.6% is the 6th highest of 10, against a peer median of +10.5%.
- Cash & equivalents amounts to 6.8% of total assets for STSS, versus a peer median of 22.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $31.13M | +89.5% | -4.0% | 86.1% | |
| Mar 2026 | $27.88M | +10.5% | +15.6% | 81.8% | |
| Mar 2026 | $21.43M | -2.2% | +34.3% | 37.0% | |
| Mar 2026 | $13.82M | -26.9% | -9.5% | 22.2% | |
| Mar 2026 | $12.32M | +3.6% | +35.5% | 6.8% | |
| Mar 2026 | $10.51M | +282.0% | — | 100.0% | |
| Mar 2026 | $9.99M | +123.4% | -21.0% | 13.3% | |
| Mar 2026 | $4.18M | -20.2% | -49.1% | 4.5% | |
| Mar 2026 | $3.85M | -43.4% | -36.7% | 4.4% | |
| Mar 2026 | $3.66M | +13.7% | +15.8% | 4.7% | |
| Peer median (excluding STSS) | $10.51M | +10.5% | -6.8% | 22.2% | |
Competitors are the stored peer set for STSS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 1.48M | 4.17M | 3.01M | 864.04K | 10.38M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 0 | 0 | 47.95K | 102.49K | 711.96K |
| Inventory | 121.99K | 185.8K | 1.71M | 1.87M | 645.27K |
| Other Current Assets | 0 | 0 | 0 | 250K | (7.17M) |
| Total Current Assets | 1.61M | 4.42M | 4.84M | 3.17M | 11.23M |
| Property, Plant & Equipment (Net) | 3.76M | 7.34M | 6.82M | 4.04M | 81.17K |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 62.48K | 52.51K | 32.5K | 250.11M |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 529.86K | 12.37K | 76.06K | 72.2K | (250.11M) |
| Total Non-current Assets | 4.29M | 7.42M | 6.95M | 4.14M | 81.17K |
| Total Assets | 5.9M | 11.84M | 11.79M | 7.31M | 269.08M |
| Account Payables | 804.14K | 543.23K | 794.11K | 976.55K | 590.69K |
| Short-term Debt | 700.02K | 0 | 0 | 3.76M | 3.08M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 585K | 1.15M | 2.42M | 98.91K | 1.02M |
| Total Current Liabilities | 2.77M | 2.01M | 3.69M | 5.19M | 4.7M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 192K | 162K | 132K | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Non-current Liabilities | 0 | 192K | 162K | 132K | 0 |
| Total Liabilities | 2.77M | 2.2M | 3.85M | 5.32M | 4.7M |
| Common Stock | 519 | 941 | 1.53K | 205 | 2.9K |
| Retained Earnings | (10.67M) | (15.31M) | (25.15M) | (34.45M) | (316.95M) |
| Accumulated OCI | (32.5K) | 214.25K | 591.81K | 23.29K | 0 |
| Other Stockholders Equity | (0) | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 3.14M | 9.64M | 7.93M | 2M | 264.38M |
| Total Debt | 700.02K | 0 | 0 | 3.76M | 3.08M |
| Net Debt | (779.15K) | (4.17M) | (3.01M) | 2.9M | (7.3M) |
SkyAI, Inc.
NASDAQ:STSS
Intrinsic Alpha fair value
Locked
Current Price
$1.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.